HR 6482 · 116th Congress 2019–2021, ended

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Latest action · Jul 13, 2020 Referred to the Subcommittee on Oversight and Investigations.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 10, 2020
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.

Cosponsors 11

Members who signed on, in the order they did. Signatures ran from Apr 10, 2020 to Oct 27, 2020; 3 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-NYElise M. StefanikOriginalApr 10, 2020
R-WYLiz CheneyOriginalApr 10, 2020
R-NCTed BuddOriginalApr 10, 2020
D-NJJefferson Van DrewApr 28, 2020
R-FLBill PoseyMay 8, 2020
R-MOVicky HartzlerMay 8, 2020
R-PRJenniffer González-ColónMay 15, 2020
R-AZAndy BiggsMay 22, 2020
R-AZDebbie LeskoJun 8, 2020
R-INJames R. BairdJul 1, 2020
R-OHMichael R. TurnerOct 27, 2020

Committees 4

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 10, 2020
HouseWays and Means Committee
Referred Apr 10, 2020
Health Subcommittee
Referred Apr 10, 2020
HouseArmed Services Committee
Referred Apr 10, 2020
HouseVeterans' Affairs Committee
Referred Apr 10, 2020
Oversight and Investigations Subcommittee
Referred Jul 13, 2020

Actions 4

Everything that happened, newest first.

  1. Jul 13, 2020Referred to the Subcommittee on Oversight and Investigations.
  2. Apr 10, 2020Introduced in House
  3. Apr 10, 2020Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Apr 10, 2020Referred to the Subcommittee on Health.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 3

The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 69, April 10, 2020, page H1883.

CRS reports 2

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 2

Products on other subjects that cite it, usually among other measures.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 3537Protecting Our Pharmaceutical Supply Chain from China Act of 2020Identical billMar 19, 2020
S 3635Protecting Our Pharmaceutical Supply Chain from China Act of 2020Related billMay 6, 2020

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes.
Short Title(s) as Introduced
Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 10, 2020Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.